Stroke
February 2015 stroke unit treatment; thrombolysis; dysphagia screening; antiplatelet therapy; and anticoagulation in atrial fibrillation. The effect of factors associated with delivery of appropriate care was estimated by hierarchical logistic regression analyses. For estimating odds ratios and resulting 95% confidence intervals, distinct multilevel models were built, taking into account clustering of patients within regions/countries. Cross-level interactions between first-level (patients) and second-level (country/region) variables were assessed. For estimating variations of adherence by center, standardized ratios were calculated by comparing the observed proportion of an indicator within a center with the proportion expected when factor-specific event rates in the respective audit derived from multiple logistic regression models were applied to the center-specific population.
Results
Audit and patient's characteristics are presented in Table I in the online-only Data Supplement; data collection details are presented in Table II in the online-only Data Supplement. Adherence to QIs varied substantially across audits (Table 1 ). Figure I in the online-only Data Supplement shows the observed adherence to QIs by the expected adherence based on the center-specific case-mix. Patient characteristics influenced delivery of appropriate care in univariable (Table III in the online-only Data Supplement) and multivariable analyses ( Table 2 ). No significant crosslevel interactions were found for QIs between patient characteristics and region/country, including missing variables did not change associations substantially (data not shown).
Discussion
Substantial variations in adherence to QIs were identified between 6 audits in Europe, especially for thrombolysis, dysphagia screening, and anticoagulant therapy. Patient characteristics, such as age, sex, or stroke subtype, were identified that were associated with delivery of appropriate care.
A consistent proportion of 3 quarters or more of patients were treated on a stroke unit, a higher proportion compared with reports from Canada.
2 Different stroke unit definitions between healthcare systems might limit comparability of findings. Substantial variations in tissue-type plasminogen activator -rates were found between audits ranging from 1.3% to 9.1%. The higher proportion of tissue-type plasminogen activator in previous studies might be because of differences in study populations (eg, considering exclusion criteria for tissue-type plasminogen activator). 3 The proportions of patients with ischemic stroke with atrial fibrillation and anticoagulant therapy at discharge ranged between 23.7% and 57.3% in our study. Substantial higher rates were observed in previous studies from the United States. 4 However, in contrast to our data, in the later study patients were excluded if a contraindication was documented. 4 Homogeneous patterns between proportions of appropriate healthcare delivery observed and proportions expected within centers were documented for antiplatelet and anticoagulant therapy, indicating that these measures might have already been translated successfully into clinical practice.
Similar to our data, previous studies have shown that older patients receive less often anticoagulation if they experience atrial fibrillation 5, 6 and more often a swallow screening. 7 This might be because of the fact that older age is associated with more severe strokes being associated with higher risk of complications. In accordance with our findings, other studies have found sex differences in diagnosis and treatment. 8 The study was designed retrospectively; therefore, no common definitions and methods were used for data collection. Potential selection biases might have contributed to our findings as in some audits participation was voluntary. No uniform criteria were applied for ensuring completeness of case ascertainment. We cannot exclude that some of our findings were caused by potential confounders. No outcome data, such as in-hospital mortality, could be calculated because of limited data availability. Data were derived from 2007 to 2008, and current treatment patterns within regions/audits might be substantially different.
Differences in adherence to QI might indicate population subgroups with specific needs for improving care delivery. CI indicates confidence; n.a., not applicable; and OR, odds ratio. *Hierarchical multilevel model. †Ischemic stroke patients aged 18-80 years. ‡In patients with ischemic stroke, intracranial hemorrhage, and stroke not known whether ischemic or hemorrhagic. §Anytime during stay or at discharge or recommended (not available in all audits) at discharge in patients with ischemic stroke and atrial fibrillation alive at discharge. ||Anytime during stay or at discharge or recommended at discharge in patients with ischemic stroke alive at discharge without anticoagulant therapy. by guest on January 30, 2018 SUPPLEMENTAL MATERIAL Tables: 3   Figures: 5 Word count: 1595 *Analysis restricted to patients with ischemic stroke, intracerebral haemorrhage or undefined stroke and without missing values in the respective variables; audits not documenting a respective variable in a comparable way were excluded; n.a. -not applicable as quality indicator did include the specific subgroup; $ oldest age group restricted to 80 years; # ischemic stroke patients age 18-80 y; † patients with ischemic stroke, intracerebral haemorrhage or undefined stroke; ‡ anytime during stay or at discharge or recommended (not available in all audits) at discharge in patients with ischemic stroke and atrial fibrillation alive at discharge; | | anytime during stay or at discharge or recommended at discharge in patients with ischemic stroke alive at discharge and without anticoagulant therapy. For estimating variations of adherence to predefined QI by center, standardized ratios on the center level were calculated by comparing the observed proportion of an indicator within a center with the proportion expected when factor-specific event rates in the respective audit derived from multiple logistic regression models were applied to the center-specific population. 
Acknowledgments

Wiedmann et al Quality of Stroke Care in 6 European Audits 581
Sources of Funding
METHODS
Data definitions
Statistical analyses
Variations in acute stroke care between the participating audits were assessed by calculating adherence to predefined quality indicators with definitions described above. The impact of factors associated with delivery of appropriate care within the audit data sets was estimated by hierarchical logistic regression analyses. Age group, sex, day of admission, comorbidities (atrial fibrillation), stroke subtype, and time from onset to admission (for the indicator thrombolytic therapy) were investigated as patient and clinical characteristics potentially influencing quality of care. For estimating odds ratios (OR) and resulting 95% confidence intervals (CI) for these factors, distinct multilevel models were built for each of the defined QI, taking into account clustering of patients within audits. This approach allows the simultaneous examination of the effects of the individual patient and clinical characteristics (first-level) and the region/country (second-level). A mixed model with a random region/country effect was applied modeling the random region effect as a G-side effect using the SAS procedure GLIMMIX. At estimation the variance matrix is blocked by region/country, which means the marginal variance matrix is assumed block-diagonal and patients from the same region/country form the blocks. We investigated whether strengths and direction of patient-level factors depends on the second level factor (region/country). For this we added terms for random cross-level interactions between first-level (age, sex, weekday of admission, atrial fibrillation, stroke subtype and time from onset to hospitalization (if applicable)) and second-level (region/country) variables. With this we used statistical tests for significant differences between the effects of a first-level factor between regions/countries. For estimating variations of adherence to predefined QI at the center level within the audits, we also calculated standardized ratios on the center level (trust, hospital or department) for the defined QI. For this purpose, an indirect standardization method was used comparing the observed proportion in a respective center with the proportion expected when factor-specific event rates in the respective country or region of the center applied to the specific center population. The respective expected proportions were derived from multiple logistic regression models adjusted for age, sex, weekday of admission, stroke subtype (if applicable), time from onset to admission (for thrombolysis), and atrial fibrillation. The sum and the mean of the predicted outcome probabilities was calculated for each hospital within a region/country providing the denominator for the observed to expected ratio. Analyses for estimating the observed/ expected ratio were restricted to hospitals with at least 10 complete cases per hospital for the QI thrombolysis, dysphagia screening, SU treatment and antiplatelet therapy or at least 5 complete cases per hospital for the quality indicator anticoagulation. Graphical presentation of O/E ratios was restricted to a ratio of four for thrombolytic therapy. All analyses were restricted to patients without missing values. The number of patients with missing values ranged for example from 0% for age, sex, or AF in at least 3 of the audits up to 38.9% for dependency pre-stroke in ADSR. Sensitivity analyses were performed to assess the potential impact of missingness, such as full data set analysis with missing values as own category, showing no substantial variations to complete case analyses. All tests were twotailed and statistical significance was determined at an alpha level of 0.05. Statistical analyses were performed using the SAS 9.2 Software Package.
